(Q33731578)

29 July 2017

1 reference

title

Biologic properties and therapeutic potential of glucagon-like peptide-2. (English)

1 reference

29 July 2017

D J Drucker

1

1 reference

29 July 2017

R P Boushey

2

1 reference

29 July 2017

F Wang

3

1 reference

29 July 2017

M E Hill

4

1 reference

29 July 2017

P L Brubaker

5

1 reference

29 July 2017

B Yusta

6

1 reference

29 July 2017

publication date

1 September 1999

1 reference

Journal of Parenteral and Enteral Nutrition

29 July 2017

published in

1 reference

29 July 2017

volume

23

1 reference

29 July 2017

issue

5 Suppl

1 reference

29 July 2017

page(s)

S98-100

1 reference

Circulating and tissue forms of the intestinal growth factor, glucagon-like peptide-2.

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F014860719902300524

Endocrine tumour in kidney affecting small bowel structure, motility, and absorptive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F014860719902300524

Glucagonoma syndrome demonstrating giant duodenal villi

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F014860719902300524

Induction of intestinal epithelial proliferation by glucagon-like peptide 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F014860719902300524

Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F014860719902300524

Cloning, functional expression, and chromosomal localization of the human pancreatic islet glucose-dependent insulinotropic polypeptide receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F014860719902300524

Expression cloning and signaling properties of the rat glucagon receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F014860719902300524

Human glucagon-like peptides 1 and 2 activate rat brain adenylate cyclase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F014860719902300524

Both Subcutaneously and Intravenously Administered Glucagon-Like Peptide I Are Rapidly Degraded From the NH2-Terminus in Type II Diabetic Patients and in Healthy Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F014860719902300524

Inhibition of the activity of dipeptidyl-peptidase IV as a treatment for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F014860719902300524

10.1177/014860719902300524

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference